We report the characterization of a new insulinotropic compound, 4-hyd
roxyisoleucine. This amino acid has been extracted and purified from f
enugreek seeds, which are known in traditional medicine for their anti
diabetic properties. 4-Hydroxyisoleucine increases glucose-induced ins
ulin release, in the concentration range of 100 mu mol/l to 1 mmol/l,
through a direct effect on isolated islets of Langerhans from both rat
s and humans. The stimulating effect of 4-hydroxyisoleucine was strict
ly glucose dependent; indeed, ineffective at low (3 mmol/l) or basal (
5 mmol/l) glucose concentrations, the amino acid potentiated the insul
in secretion induced by supranormal (6.6-16.7 mmol/l) concentrations o
f glucose. In addition, in the isolated perfused rat pancreas, we coul
d show 1) that the pattern of insulin secretion induced by 4-hydroxyis
oleucine was biphasic, 2) that this effect occurred in the absence of
any change in pancreatic alpha- and delta-cell activity, and 3) that t
he more glucose concentration was increased, the more insulin response
was amplified. Moreover, 4-hydroxyisoleucine did not interact with ot
her agonists of insulin secretion (leucine, arginine, tolbutamide, gly
ceraldehyde). Therefore, we conclude that 4-hydroxyisoleucine insulino
tropic activity might, at least in part, account for fenugreek seeds'
antidiabetic properties. This secretagogue may be considered as a nove
l drug with potential interest for the treatment of NIDDM.